Home can be different things, ranging from where you sleep to the entire planet. All of it requires care and maintenance. We should do more of that.

Stand up for something. What do you need to have explained? Have a frickin' backbone. Decide what is important. Fight to keep it or work to change it. Figure it out.

Introducing solid foods is a transformative milestone in an infant’s growth. This week on Raising Parents: The Parenting Science Insights Podcast, host Marie Stella interviews nutrition education consultant Rachel Schichtl for advice on incorporating solid foods into an infant’s diet, and the nutritional benefits it offers.A registered dietitian and nutritionist, Rachel Schichtl Ph.D., RD, CFCS, FAND possesses a PhD in family and consumer sciences education, and has been inducted as a fellow of the

In the evolving church of science, we understand our mental information is sorted into personal beliefs (which are not verified) and knowledge (which is verified through multiple external sources). When we make choices about our actions, we are encouraged to use as much information as we can, because that makes the actions more likely to reach the desired goals. We should all be doing a little more math...

For decades, clinical trial recruitment has been the biggest challenge in the industry. Christine Senn, senior vice president of Site-Sponsor Innovation at Advarra, offers insights into why the struggle continues, such as delays in getting regulations updated after a quarter of a century, and how to overcome the deadlock in clinical trial recruitment that is tied to current obsolete marketing guidelines. Also, host Deborah Borfitz shares the latest on beta blockers, low dose aspirin lowering ...

When it comes to biotech innovation, data and logic should drive decision-making, but sometimes stories take the wheel. This week, I spoke to Julien Willard, a board advisor and strategist for biopharma leaders. He had written a post on LinkedIn about how biologics may be favored over small molecules when logic suggests otherwise.Despite perceptions, small molecules still make up 73% of all FDA approvals from 2009 to 2023. They’re faster and cheaper to develop with median costs around $2.1 billion

Send us a text اپیزود ۵۸ از پادکست نوش دارو به بهانه گذر از روز جهانی سالمندی منتشر می شود و نگاهی دارد به ساده ترین و ملموس ترین ابعاد زندگی سالمندان در سراهای سالمندی … سراهایی به وسعت یک روستا ،به وسعت یک شهر ،به وسعت یک کشور ،به وسعت کشوری که دارد پیر می شود ….. ایران کشوری است که با سرعتی حیرت انگیز تر از سرعت رشد سالمندی در جهان دارد پیر می شود و این اپیزود نگاهی دارد به ساده ترین نیازهای روزگار پیری و مراقبینی که خود می توانند پیر یا در استانه ی پیری باشند . در ...

In this episode of the Driving the Business of Science podcast, hosted by Keith Parent, CEO of Court Square Group, guest Mark Connell, Co-Founder and President of SLBST Pharma, discusses the company’s mission to repurpose hydroxychloroquine to treat endometriosis, a condition affecting 7 million American women. Despite limited current therapies, SLBST Pharma aims to leverage the drug’s proven efficacy in reducing lesions by 60%. Challenges include navigating the complexities of drug developme...

„Kelionės išmokė ir kasdieniame gyvenime turėti mažiau daiktų. Daiktai kainuoja, bet kelionės irgi kainuoja“, - sako keliautoja, tinklaraščio „Check in Lithuania“ autorė Diana Gedeikytė-Jakutienė. Lietuvos takus ir pasaulio kalnus išmaišiusi pašnekovė dalijasi, kaip keitėsi jos santykis su daiktais pradėjus vykti į patyrimines keliones, ko nebeprisikrauna į kuprinę bei ką patartų kiekvienam, norinčiam į artimiausią nuotykį vykti su kuo mažiau daiktų.Ved. Karolina Panto

Hello and welcome to PhageLine - your line to everything phage.This week, we will discuss the effect of an antibiotic and a probiotic on phage communities in swine gut microbiota as featured in a recent paper by Lemieux et al. in BMC Research Notes. Have fun!This episode was generated using artificial intelligence.

A podcast by Dr. Jiri Snaidr exploring the hidden world of microorganisms that shape our lives. Episode We inhale them every day – tiny, invisible forms of life carried by every breath of air we take. This episode dives into the fascinating world of airborne microbes: how they influence our microbiome, which types float around us, and why their diversity can affect our health, allergies, and immune system. From city smog to mountain air – the composition of the microbial cloud surrounding

The source provides an extensive overview of the enduring debate surrounding the existence of ghosts, examining the topic through multiple viewpoints including science, skepticism, history, and paranormal research. It explains that while ghosts are a nearly universal cultural construct used to process loss and societal fears, a significant percentage of the population reports personal encounters, prompting scientific investigation. Skeptical perspectives offer neurological and environmental

Podcastimizin 100. bölümünde başlığımız “Olumsuzluğa Takılmak, Hep Kötüyü Düşünmek” oldu. Beğeneceğinizi umuyoruz, iyi seyirler.

Love Frontline Nursing? Let us know Janice Adams, DNP, MPA, RN, joins Florida Center for Nursing Executive Director Rayna Letourneau, PhD, RN, for a conversation about the importance of workforce data, retiring multiple times, and looking at the big picture. Dr. Adams earned her Doctor of Nursing Practice in Executive Leadership from American Sentinel University in Aurora, CO. She earned her Master of Public Administration from Troy State University, her Bachelor of Science in Nursing ...

Podcastimizin 99. bölümünde başlığımız “Kendini Bilmek: Öz Farkındalık” oldu. Beğeneceğinizi umuyoruz, iyi seyirler.

In this episode, host David Brühlmann is joined by Alois Jungbauer, Professor Emeritus at BOKU University, Vienna, and Scientific Advisor at BioChromatographix International. With over 40 years in bioprocess engineering and more than 400 published papers, Jungbauer offers a unique perspective on how downstream processing and purification technologies have evolved and where they’re headed next. Alois shares his unconventional journey into the world of biotech, starting from humble beginnings o...

Zombies might seem like the stuff of horror movies, but there are lots of examples of parasites taking over bugs’ bodies and bending them to their will.Guest: Mindy Weisberger, author of Rise of the Zombie Bugs: The Surprising Science of Parasitic Mind-Control For show transcripts, go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠vox.com/unxtranscripts⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠For more, go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠vox.com/unexplainable⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠And please email us! ⁠⁠⁠unexplainable@vox.com⁠⁠⁠We read every email.Support Unexplainable (and

Left-handers make up about 10.6 percent of the world’s population. Sebastian Ocklenburg, PhD, talks about why handedness and other brain asymmetries exist; the genetic and environmental factors that influence handedness; whether there’s any truth to the stereotype that lefties are more creative; why “pawedness” is common in cats, dogs, and other non human animals; and why left-handed people are underrepresented in brain research.Learn more about your ad choices. Visit megaphone.fm/adchoices

Welcome to the first episode of The Threshold, a Foreign Policy podcast about the fight to end infectious diseases around the world and the innovations that could get us there. Host Henry Bonsu speaks with Gates CEO Mark Suzman and WACI Health Executive Director Rosemary Mburu about why they’re both optimistic and concerned about the future of disease elimination. And there is a big deadline on their minds that directly impacts the state of global health—which is in a tough place.  More than two

Bronchopulmonary dysplasia is a condition that affects preterm infants, especially those born with underdeveloped lungs who require prolonged oxygen therapy or mechanical ventilation to help them breathe after birth. It is characterized by damage and abnormal development of the lung tissue and airways, often resulting from life-saving interventions necessary for babies born very prematurely. Airway Therapeutics is developing a new class of biologics for respiratory and inflammatory diseases,